We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$720M
AUM Growth
+$115M
Cap. Flow
+$87.4M
Cap. Flow %
12.13%
Top 10 Hldgs %
49.83%
Holding
741
New
103
Increased
58
Reduced
70
Closed
92

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.48%
2 Financials 7.1%
3 Energy 5.05%
4 Technology 4.9%
5 Healthcare 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
126
American International
AIG
$41.9B
$428K 0.06%
7,842
+7,100
+957% +$376K
EOG icon
127
EOG Resources
EOG
$78B
$416K 0.06%
3,564
VZ icon
128
Verizon
VZ
$194B
$416K 0.06%
8,510
VIAB
129
DELISTED
Viacom Inc. Class B
VIAB
$413K 0.06%
4,741
-15
-0.3% -$1.27K
BRK.B icon
130
Berkshire Hathaway Class B
BRK.B
$1.07T
$412K 0.06%
3,255
+2,350
+260% +$297K
BHI
131
DELISTED
Baker Hughes
BHI
$402K 0.06%
5,400
HON icon
132
Honeywell
HON
$77B
$390K 0.05%
4,674
-779
-14% -$65.1K
RMD icon
133
ResMed
RMD
$28.3B
$390K 0.05%
7,700
FMC icon
134
FMC
FMC
$1.42B
$370K 0.05%
5,996
GM icon
135
General Motors
GM
$74.7B
$370K 0.05%
10,200
-900
-8% -$31.4K
TWC
136
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$367K 0.05%
2,491
KMI icon
137
Kinder Morgan
KMI
$73.1B
$366K 0.05%
10,085
ESRX
138
DELISTED
Express Scripts Holding Company
ESRX
$366K 0.05%
5,280
+3,800
+257% +$267K
OCR
139
DELISTED
OMNICARE INC
OCR
$366K 0.05%
5,500
CVSA
140
Covista Inc
CVSA
$3.94B
$359K 0.05%
8,478
CB icon
141
Chubb
CB
$140B
$358K 0.05%
3,450
FCX icon
142
Freeport-McMoran
FCX
$90B
$353K 0.05%
9,675
NBL
143
DELISTED
Noble Energy, Inc.
NBL
$352K 0.05%
4,540
+2,300
+103% +$167K
KR icon
144
Kroger
KR
$34.8B
$348K 0.05%
14,086
+13,992
+14,885% +$326K
UHS icon
145
Universal Health Services
UHS
$9.43B
$345K 0.05%
3,600
TW
146
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$342K 0.05%
3,277
LOW icon
147
Lowe's Companies
LOW
$116B
$338K 0.05%
7,049
+9
+0.1% +$420
BHC icon
148
Bausch Health
BHC
$1.65B
$333K 0.05%
2,639
+600
+29% +$76.5K
GILD icon
149
Gilead Sciences
GILD
$161B
$332K 0.05%
4,000
+800
+25% +$62.3K
IVZ icon
150
Invesco
IVZ
$13.3B
$328K 0.05%
8,700

Similar funds

Hirtle Callaghan & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Hirtle Callaghan & Co held 741 positions worth $720M, up 19% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co deployed $87.4M of net new capital in Q2 2014, opening 103 new positions and adding to 58 existing holdings. Its largest new stake was Goldman Sachs: 26,355 shares worth $4.41M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 24% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Teledyne Technologies, an estimated $1M trimmed.

  • Hirtle Callaghan & Co's largest Q2 2014 buy was Goldman Sachs: 26,355 shares worth $4.41M.
  • Hirtle Callaghan & Co added most to iShares Russell Mid-Cap ETF in Q2 2014, an estimated $516K increase.
  • Hirtle Callaghan & Co's biggest Q2 2014 reduction was Teledyne Technologies, cutting an estimated $1M.
  • Hirtle Callaghan & Co fully exited iShares MSCI EAFE ETF in Q2 2014, selling an estimated $26M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $720M portfolio in Q2 2014.
  • Hirtle Callaghan & Co opened 103 new positions and closed 92 in Q2 2014.
  • Hirtle Callaghan & Co's portfolio value rose 19% quarter-over-quarter to $720M.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.